Novel Adapter Proteins that Link the Human GM-CSF Receptor to the Phosphatidylino-sitol 3-Kinase and Shc/Grb2/ras Signaling Pathways

  • M. Jücker
  • R. A. Feldman
Conference paper
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 211)


We have used a human GM-CSF-dependent hematopoietic cell line that responds to physiological concentrations of hGM-CSF to analyze a set of signaling events that occur in normal myelopoiesis and whose deregulation may lead to leukemogenesis. Stimulation of these cells with hGM-CSF induced the assembly of multimeric complexes that contained known and novel phosphotyrosyl proteins. One of the new proteins was a major phosphotyrosyl substrate of 76–85 kDa (p80) that was directly associated with the p85 subunit of phosphatidylinositol (PI) 3-kinase through the SH2 domains of p85. p80 also associated with the β subunit of the activated hGM-CSF receptor, and assembly of this complex correlated with activation of PI 3-kinase. A second phosphotyrosyl protein we identified, pi40, associated with the She and Grb2 adapter proteins by direct binding to a novel phosphotyrosine-interacting domain located at the N-terminus of She, and to the SH3 domains of Grb2, respectively. The Shc/pl40/Grb2 complex was found to be constitutively activated in acute myeloid leukemia cells, indicating that activation of this pathway may be a necessary step in the development of some leukemias. The p80/p85/PI 3-kinase and the Shc/Grb2/pl40 complexes were tightly associated with Src family kinases, which were prime candidates for phosphorylation of She, p80, pl40 and other phosphotyrosyl substrates pesent in these complexes. Our studies suggest that p80 and pl40 may link the hGM-CSF receptor to the PI 3-kinase and Shc/Grb2/ras signaling pathways, respectively, and that abnormal activation of hGM-CSF-dependent targets may play a role in leukemogenesis.


Acute Myeloid Leukemia Acute Myeloid Leukemia Cell NPXY Motif Oncogenic Tyrosine Kinase Grb2 Adapter Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Areces LB, Jücker M, San Miguel J, Mui A, Miyajima A Feldman RA (1993) Ligand-dependent transformation by the receptor for human granulocyte/macrophage colony-stimulating factor and tyrosine phosphorylation of the receptor (3 subunit. Proc Natl Acad Sci USA 90: 3963–3967PubMedCrossRefGoogle Scholar
  2. 2.
    Auger KR, Serunian LA, Soltoff SP, Libby P, Cantley LC (1989) PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositosides in intact cells. Cell 57:167–175PubMedCrossRefGoogle Scholar
  3. 3.
    Blaikie P, Immanuel D, Wu J, Li V, Margolis B (1994) A region of SHC distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. J Biol Chem 269:32031–32034PubMedGoogle Scholar
  4. 4.
    Carpenter CL, Duckworth BC, Auger KR, Cohen B, Schaffhausen BS, Cantley LC (1990) Purification and characterization of phosphoinositide 3-kinase from rat liver. J Biol Chem 265:19704–19711PubMedGoogle Scholar
  5. 5.
    Corey S, Eguinoa A, Puyana-Theall K, Bolen JB, Cantley L, Molinedo F, Jackson TR, Hawkins PT, Stephens LR (1993) Granulocyte macrophage-colony stimulating factor stimulates both association and activation of phosphoinositide 30H-kinase and src-related tyrosine kinase(s) in human myeloid derived cells. EMBOJ 12:2681–2690Google Scholar
  6. 6.
    Egan SE, Giddlings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA (1993) Association of Sos ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363:45–51PubMedCrossRefGoogle Scholar
  7. 7.
    Fantl WJ, Escobedo JA, Martin GA, Turck CW, del Rosario M, McCormick F, Williams, LT. (1992) Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell 69:413–423PubMedCrossRefGoogle Scholar
  8. 8.
    Gustafson TA, He W, Craparo A, Schaub CD, O’Neil TJ (1995) Phosphotyrosine-dependent interaction of SHC and Insulin Receptor Substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol Cell Biol 15:2500–2508PubMedGoogle Scholar
  9. 9.
    Hayashida K, Kitamura T, Gorman DM, Arai KI, Yokota T, Miyajima A (1990) Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci USA 87:9655–9659PubMedCrossRefGoogle Scholar
  10. 10.
    Hu P, Margolis B, Skolnik EY, Lammers R, Ullrich A, Schlessinger J (1992) Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Mol Cell Biol 12:981–990PubMedGoogle Scholar
  11. 11.
    Jücker M, Feldman RA, SubmittedGoogle Scholar
  12. 12.
    Kavanough WM, Williams LT (1994) An alternative to SH2 domains for binding to tyrosine phosphorylated receptors. Science 266:1862–1865CrossRefGoogle Scholar
  13. 13.
    Kavanough WM, Klippel A, Escobedo JA, Williams LT (1992) Modification of the 85 kilodalton subunit of phosphatidylinositol-3 kinase in platelet-derived growth factor-stimulated cells. Mol Cell Biol 12:3415–3424Google Scholar
  14. 14.
    Keegan AD, Nelms K, White M,Wang L-M, Pierce JH, Paul,W (1994) An EL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 76:811–820Google Scholar
  15. 15.
    Kitamura T, Tange T, Terasawa T, China S, Kuwaki T, Miyagawa K, Piao Y-F, Miyazono K, Urabe A, Takaku F (1989) Establishment and characterization of a unique human cell line mat proliferates dependency on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 140:323- 334CrossRefGoogle Scholar
  16. 16.
    Kitamura T, Sato N, Arai K-I, Miyajima A (1991) Expression cloning of the human IL-3 receptor cDNA reveals a shared β subunit for human IL-3 and GM-CSF receptors. Cell 66:1165–1174PubMedCrossRefGoogle Scholar
  17. 17.
    Klippel A, Escobedo JA, Hu Q, Williams L (1993) A region of the 85-kilodalton (kDa) subunit of phosphatidylinositol 3-kinase binds the 110-kDa catalytic subunit in vivo. Mol Cell Biol 13:5560–5566PubMedGoogle Scholar
  18. 18.
    Lanfrancone L, Pelicci G, Brizzi MF, Arouica MG, Casciari C, Giuli S, Pegoraro L, Pawson T, Pelicci PG (1995) Overexpression of She proteins potentiates the proliferative response to the granulocyte-macrophage colony-stimulating factor and recruitment of Grb2/SoS and Grb2/pl40 complexes to the receptor p subunit. Oncogene 10:907–917PubMedGoogle Scholar
  19. 19.
    Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, LammersR, Ullrich A, Skolnik EY, Bar-Sagi D, Schlessinger J (1992) The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70:431–442Google Scholar
  20. 20.
    McGlade J, Cheng A, Pelicci G, Pelicci P-G, Pawson T (1992) She proteins are phosphorylated and regulated by the v-src and v-fps protein-tyrosine kinases. Proc Natl Acad Sci (USA) 89:8869–8873CrossRefGoogle Scholar
  21. 21.
    McGlade CJ, Ellis C, Reedijk M, Anderson D, Mbamalu, Reith AD, Panayotou G, End P, Bernstein A, Kazlauskas A, Waterfield MD, Pawson T (1992) SH2 domains of the p85α subunit of phosphatidylinositol 3-kinase regulate binding to growth factor receptors. Mol Cell Biol 12:991–997PubMedGoogle Scholar
  22. 22.
    Metcalf D (1989) The molecular control of cell division, differentiation cornmitment and maturation in haemopoietic cells. Nature 339:27–30PubMedCrossRefGoogle Scholar
  23. 23.
    Miyajima A, Kitamura T, Harada N, Yokota, T, Arai K-I (1992) Cytokine receptors and signal transduction. Annu Rev Immunol 10:295–331.PubMedCrossRefGoogle Scholar
  24. 24.
    Pleiman CM, Hertz W M, Cambier JC (1994) Activation of phosphatidylinositol-3’ kinase by sre-family SH3 binding to the p85 subunit. Science 263:1609–1612PubMedCrossRefGoogle Scholar
  25. 25.
    Pellici G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, Forni G, Nicoletti I, Grignani F, Pawson T, Pelicci PG (1992) A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70: 93–104CrossRefGoogle Scholar
  26. 26.
    Quelle FW, Shimoda K, Thierfelder W, Fischer, C, Kim A, Ruben SM, Cleveland JM, Pierce JH, Keegan AD, Nelms K, Paul WE, Ihle JN (1995) Cloning of murine Stat6 and human Stat6, Stat proteins mat are tyrosine phosphorylated in responses to DL-4 and EL-3 but are not required for mitogenesis. Mol Cell Biol 15:3336–3343PubMedGoogle Scholar
  27. 27.
    Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R., Li W, Batzer A, Thomas S, Brugge J, Pelicci P G, Schlessinger J, Pawson T (1992) Association of the She and Grb2/Sem5 SH2-containing proteins is implicated in activation of the ras pathway by tyrosine kinases. Nature 360:689–692PubMedCrossRefGoogle Scholar
  28. 28.
    Sachs L (1990) The control of growth and differentiation in normal and leukemic blood cells. Cancer 65:2196–206PubMedCrossRefGoogle Scholar
  29. 29.
    Silvennoinen O, Witthuhn B, Quelle FW, Cleveland JL, Yi T, Ihle JN (1993) Structure of the JAK-2 protein tyrosine kinase and its role in IL-3 signal transduction. Proc Natl Acad Sci USA 90:8429–8433PubMedCrossRefGoogle Scholar
  30. 30.
    Skolnik EY, Lee C-H, Batzer A, Vincentini LM, Zhou M, Daly R, Myers Jr MJ, Backer JM, Ullrich A, White MF, Schlessinger J (1993) The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS 1 and She: implications for insulin control of ras signalling. EMBOJ 12:1929–1936Google Scholar
  31. 31.
    Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White M (1991) Structure of the Insulin Receptor Substrate IRS-1 defines a unique signal transduction protein. Nature 352:73–77PubMedCrossRefGoogle Scholar
  32. 32.
    Torigoe T, O’Connor R, Santoli D, Reed JC (1992) Interleukin-3 regulates the activity of the LYN protein-tyrosine kinase in myeloid-committed leukemic cell lines. Blood 80:617–624PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • M. Jücker
    • 1
  • R. A. Feldman
    • 1
    • 2
  1. 1.Department of Microbiology and ImmunologyUniversity of Maryland School of MedicineBaltimoreUSA
  2. 2.Medical Biotechnology CenterUniversity of Maryland Biotechnology InstituteBaltimoreUSA

Personalised recommendations